Statewide newborn screening for Pompe disease began in Illinois in 2015. As of 30 September 2019, a total of 684,290 infants had been screened and 395 infants (0.06%) were screen positive. A total of 29 cases of Pompe disease were identified (3 infantile, 26 late-onset). While many of the remainder were found to have normal alpha-glucosidase activity on the follow-up testing (234 of 395), other findings included 62 carriers, 39 infants with pseudodeficiency, and eight infants who could not be given a definitive diagnosis due to inconclusive follow-up testing
Background: Newborn screening is a public health program to identify conditions associated with sign...
© 2009 Yvette M. CurlisPompe disease is a rare autosomal recessive condition caused by a deficiency ...
Background: Neonatal screening for Pompe disease has been introduced in Taiwan and a few U. S. state...
OBJECTIVE: Pompe disease is an autosomal recessive lysosomal storage disorder that is caused by defi...
BACKGROUND. Pompe disease is a lysosomal storage disorder that leads to the accumulation of glycogen...
Pompe disease is an inherited lysosomal storage disorder caused by acid alpha-glucosidase (GAA) enzy...
Introduction:Pompe disease is a lysosomal storage disorder caused by a deficiency in acid -glucosida...
OBJECTIVE: Pompe disease causes progressive, debilitating, and often life -threatening musculoskelet...
: Pompe disease (PD) is a progressive neuromuscular disorder caused by a lysosomal acid α-glucosidas...
Newborn screening (NBS) for Pompe disease is done through analysis of acid alpha-glucosidase (GAA) a...
Background: Pompe disease is caused by a deficiency in acid alpha-glucosidase (GAA) and results in p...
Pompe disease, also known as acid maltase deficiency or acid alpha-glucosidase deficiency, in its mo...
Background: Neonatal screening for Pompe disease has been introduced in Taiwan and a few U.S. states...
[[sponsorship]]生物醫學科學研究所[[note]]已出版;[SCI];有審查制度;具代表性[[note]]http://gateway.isiknowledge.com/gateway/...
Pompe disease (glycogen storage disease type II or acid maltase deficiency) is a lysosomal disorder ...
Background: Newborn screening is a public health program to identify conditions associated with sign...
© 2009 Yvette M. CurlisPompe disease is a rare autosomal recessive condition caused by a deficiency ...
Background: Neonatal screening for Pompe disease has been introduced in Taiwan and a few U. S. state...
OBJECTIVE: Pompe disease is an autosomal recessive lysosomal storage disorder that is caused by defi...
BACKGROUND. Pompe disease is a lysosomal storage disorder that leads to the accumulation of glycogen...
Pompe disease is an inherited lysosomal storage disorder caused by acid alpha-glucosidase (GAA) enzy...
Introduction:Pompe disease is a lysosomal storage disorder caused by a deficiency in acid -glucosida...
OBJECTIVE: Pompe disease causes progressive, debilitating, and often life -threatening musculoskelet...
: Pompe disease (PD) is a progressive neuromuscular disorder caused by a lysosomal acid α-glucosidas...
Newborn screening (NBS) for Pompe disease is done through analysis of acid alpha-glucosidase (GAA) a...
Background: Pompe disease is caused by a deficiency in acid alpha-glucosidase (GAA) and results in p...
Pompe disease, also known as acid maltase deficiency or acid alpha-glucosidase deficiency, in its mo...
Background: Neonatal screening for Pompe disease has been introduced in Taiwan and a few U.S. states...
[[sponsorship]]生物醫學科學研究所[[note]]已出版;[SCI];有審查制度;具代表性[[note]]http://gateway.isiknowledge.com/gateway/...
Pompe disease (glycogen storage disease type II or acid maltase deficiency) is a lysosomal disorder ...
Background: Newborn screening is a public health program to identify conditions associated with sign...
© 2009 Yvette M. CurlisPompe disease is a rare autosomal recessive condition caused by a deficiency ...
Background: Neonatal screening for Pompe disease has been introduced in Taiwan and a few U. S. state...